PHARMA MAR, S.A. 02/07/2020 09:30 PHARMA MAR, S.A. On business and financial situation The Company announces that its partner in South Korea, Boryung Pharmaceutical, has presented the results of in vitro studies of plitidepsin (Aplidin®) in SARS-CoV-2. Register number: 3138
